MedTrace Logo

Fiber Fermentation Study

NCT04570137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-01-08

No results posted yet for this study

Summary

The aim of the study is to better understand the interplay between the intake of dietary fiber and intestinal bacteria, their metabolic activity and the effect on the intestinal barrier.

The effect of two different dietary fiber supplements is tested (arabinoxylan \& ß-glucan versus inulin \& fructooligosaccharides) in a randomized crossover intervention trial including healthy volunteers.

Conditions

  • Intestinal Health

Interventions

DIETARY_SUPPLEMENT

Dietary fiber supplementation

1. 16g/day: mix of 70% wheat-bran arabinoxylan and 30% oat-derived fiber (ß-glucan) 2. 16g/day: mix of 50% inulin and 50% oligofructose from chicory

Sponsors & Collaborators

  • University of Hohenheim

    lead OTHER

Principal Investigators

  • Stephan C Bischoff, Prof., MD · University of Hohenheim, Institute of Nutritional Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2020-09-30
Completion
2020-10-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570137 on ClinicalTrials.gov